NCT04066361View on ClinicalTrials.gov

OPTimizing Treatment Focused Genetic Testing IN Cancer

NACompletedINTERVENTIONAL
Enrollment

301

Participants

Timeline

Start Date

December 19, 2019

Primary Completion Date

November 30, 2022

Study Completion Date

November 30, 2022

Conditions
Breast CancerOvarian CancerPancreatic CancerProstate Cancer
Interventions
OTHER

Chatbot

Interactive text chat designed to mirror the educational components of a traditional genetic counseling visit

OTHER

Video Education

Brief video designed to mirror the educational components of a traditional genetic counseling visit

Trial Locations (1)

02115

Dana Farber Cancer Institute, Boston

All Listed Sponsors
lead

Dana-Farber Cancer Institute

OTHER

NCT04066361 - OPTimizing Treatment Focused Genetic Testing IN Cancer | Biotech Hunter | Biotech Hunter